[Sleep-disordered breathing in long-term opioid therapy].

Area of Science:

• Sleep Medicine
• Pharmacology
• Neurology

Background:

• Chronic opioid use is prevalent for pain management.
• Opioids are known to affect central nervous system functions, including respiration and sleep architecture.
• Disturbed sleep and excessive daytime sleepiness are commonly reported side effects.

Observation:

• Opioid administration leads to a reduction in Rapid Eye Movement (REM) sleep and slow-wave sleep (SWS).
• Central sleep apnea (CSA) is observed in approximately 30% of individuals on chronic opioid therapy.
• Breathing disturbances, including ataxic breathing and CSA, are more pronounced during Non-Rapid Eye Movement (NREM) sleep compared to REM sleep.

Findings:

• Central sleep apnea (CSA) is a significant respiratory complication associated with chronic opioid use.
• The observed sleep disturbances, including reduced REM and SWS, are linked to opioid pharmacodynamics.
• CSA does not appear to be the sole factor responsible for excessive daytime sleepiness in this patient population.

Implications:

• Further research is needed to elucidate the full spectrum of sleep-related consequences of chronic opioid use.
• Understanding these effects is crucial for managing patients on long-term opioid therapy and mitigating adverse outcomes.
• Investigating the mechanisms underlying opioid-induced sleep disturbances may lead to novel therapeutic strategies.